Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 29

Sort by

Sort Order Select

Journal Articles

IL18-armored CAR T cells in patients with CLL/SLL and Richter's transformation after prior BTK inhibitor and venetoclax failure

Blood (2025) 146 (Supplement 1): 2394.

https://doi.org/10.1182/blood-2025-2394

Published: 2025

Journal Articles

Evaluation of outcomes by line of therapy in marginal zone lymphoma: Real-world evidence from 10 US academic centers

Narendranath Epperla, John Sharp, Natalie Grover, Marcus Watkins, Reem Karmali, Pallawi Torka, Timothy Voorhees, Colin Thomas, Stefan Barta, Praveen Ramakrishnan Geethakumari, Nancy Bartlett, Geoffrey Shouse, Adam Olszewski

Blood (2025) 146 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2025-4533

Published: 2025

Journal Articles

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Blood (2025) 146 (Supplement 1): 4523.

https://doi.org/10.1182/blood-2025-4523

Published: 2025

Journal Articles

Outcomes of patients with dual primary T-cell and B-cell lymphoid malignancies

Zachary Hing, Colin Thomas, Stephen Schuster, Daniel Landsburg, Sunita Dwivedy Nasta, Jakub Svoboda, Jordan Carter, Emeline Chong, Nicole Altomare, Reem Karmali, Venkata Preetam Sandeep Kaduluri, Cole Sterling, Danielle Miller, Zachary Frosch, Stefan Barta

Blood (2025) 146 (Supplement 1): 5409.

https://doi.org/10.1182/blood-2025-5409

Published: 2025

Journal Articles

Early administration of CD20 x CD3 bispecific antibodies 4-6 weeks after CAR-T infusion for patients with residual or progressive large B cell lymphomas

Blood (2025) 146 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2025-1952

Published: 2025

Journal Articles

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Blood (2025) 146 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2025-1054

Published: 2025

Journal Articles

Frontline experience with second generation covalent Bruton tyrosine kinase inhibitors for mantle cell lymphoma: A single center experience

Luke Maillie, Stefan Barta, Jordan Carter, Michael Cook, Mitchell Hughes, Daniel Landsburg, Sunita Dwivedy Nasta, Marco Ruella, Stephen Schuster, Jakub Svoboda, Colin Thomas, Emily Tomasulo, Elise Chong

Blood (2025) 146 (Supplement 1): 7119.

https://doi.org/10.1182/blood-2025-7119

Published: 2025

Journal Articles

Patient characteristics, treatment patterns, and outcomes in primary CNS lymphoma of T-cell origin: A multi-institution retrospective analysis

Blood (2025) 146 (Supplement 1): 893.

https://doi.org/10.1182/blood-2025-893

Published: 2025

Journal Articles

Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium

Mark Sorial, Kenechukwu Aniagboso, Emily Buttermore, Matthew Lei, Ellen Kendall, Kristiana Nasto, Min Jung Koh, Jessy Xinyi Han, Leora Boussi, Luis Malpica, Brady Beltran, Laura Korin, German Stemmelin, Carlos Chiattone, Denisse Castro, Fabiola Valvert, Jule Vasquez, Henry Quintero, Macarena Roa, Alfredo Quiroz, Marialejandra Torres Viera, Luis Mario Villela Martinez, Ana Oliver, Cesar Augusto Samanez Figari, Edith Julia, Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Laurence de Leval, Franck Morschhauser, Emmanuel Bachy, Omar Elghawy, Stefan Barta, Jack Malespini, Kusha Chopra, Caroline MacVicar, Sean McCabe, Luke Peng, Shambhavi Singh, Makoto Iwasaki, Ijeoma Eche-Ugwu, Judith Gabler, Maria J Fernandez, Alexander Disciullo, Josie Ford, Alexandra Lenart, Emmanuel Nwodo, Jeffrey Barnes, Min Ji Koh, Eliana Miranda, Robert Stuver, Mwanasha Merrill, Eric Jacobsen, Martina Manni, Monica Civallero, Tetiana Skrypets, Athina Lymboussaki, Massimo Federico, Yu Ri Kim, Jin Seok Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Epari Sridhar, Alok Shetty, Saswata Saha, Manju Sengar, Hasmukh Jain, Carrie Van Der Weyden, H. Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine Foss, Marianna Gentilini, Beatrice Casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won-Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al Mansour, Maria Elena Cabrera, Govind Bhagat, Helen Ma, Ahmed Sawas, Dhruv Mistry, Khyati Kariya, Forum Bhanushali, Maya Krishnan, Erica Lee, Owen O'Conner, Enrica Marchi, Devavrat Shah, Changyu Shen, Salvia Jain

Blood (2025) 146 (Supplement 1): 889.

https://doi.org/10.1182/blood-2025-889

Published: 2025

Journal Articles

Trends in muscle and fat metrics and their association with outcomes following CAR T-cell therapy in older adults with non Hodgkin lymphoma.

Gabriel Aleixo, Luca Paruzzo, Rakesh Sharma, Walter Witchey, Marco Ruella, Daniel Landsburg, Stefan Barta, Jakub Svoboda, Stephen Schuster, Elise Chong, Pashna Munshi, Sandra Susanibar, Sunita Dwivedy Nasta

Blood (2025) 146 (Supplement 1): 3553.

https://doi.org/10.1182/blood-2025-3553

Published: 2025

Journal Articles

A multicenter real-world analysis (RWA) of primary cutaneous anaplastic large cell lymphoma (PCALCL) treated in the era of targeted therapies

Deepa Jagadeesh, Stefan Barta, Seunghee Margevicius, Jonathan Brammer, Jeanette Comstock, Pingfu Fu, Rahul Mishra, Montreh Tavakkoli, Alma Habib, Imran Nizamuddin, Tiffany Chang, Melissa Pulitzer, Cesar Virgen, Sharina Macapagal, Madiha Iqbal, N. Nora Bennani, Frederick Lansigan, Neha Mehta-Shah, Zachary Epstein-Peterson

Blood (2025) 146 (Supplement 1): 5433.

https://doi.org/10.1182/blood-2025-5433

Published: 2025

Journal Articles

Naive CD4+ at apheresis and disease control at infusion are associated with improved efficacy in second-line CAR T-cells

Blood (2025) 146 (Supplement 1): 2755.

https://doi.org/10.1182/blood-2025-2755

Published: 2025

Journal Articles

Duration of lymphopenia after CAR-T cell therapy is associated with increased risk of non-melanoma skin cancers and decreased survival

Emeline Chong, Megan Jones, Guido Ghilardi, Luca Paruzzo, Sunita Dwivedy Nasta, Stefan Barta, Jakub Svoboda, Elise Chong, Jordan Carter, Colin Thomas, Michael Cook, Emily Tomasulo, Marco Ruella, Daniel Landsburg, Stephen Schuster

Blood (2025) 146 (Supplement 1): 3728.

https://doi.org/10.1182/blood-2025-3728

Published: 2025

Journal Articles

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden

Blood (2025) 146 (Supplement 1): 560.

https://doi.org/10.1182/blood-2025-560

Published: 2025

Journal Articles

CD19-directed CAR T-cell therapy for B-cell lymphoid malignancies is safe and effective in people living with HIV (PWH) – a matched cohort analysis by the center for international blood and marrow transplant research (CIBMTR) and the AIDS malignancy consortium (AMC)

Stefan Barta, Ariela Noy, Kwang Woo Ahn, Jinalben Patel, Tiffany Hunt, Uroosa Ibrahim, Robert Baiocchi, Deukwoo Kwon, Marcelo Pasquini, Richard Ambinder

Blood (2025) 146 (Supplement 1): 955.

https://doi.org/10.1182/blood-2025-955

Published: 2025

Journal Articles

Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study

Blood (2025) 146 (Supplement 1): 7189.

https://doi.org/10.1182/blood-2025-7189

Published: 2025

Journal Articles

Risk factors for failure to complete step-up-dosing of bispecific antibody therapy for B-cell lymphomas

Michael Cook, Emeline Chong, Ava Clifford, Daniel Landsburg, Sunita Dwivedy Nasta, Elise Chong, Stefan Barta, Jakub Svoboda, Jordan Carter, Colin Thomas, Emily Tomasulo, Stephen Schuster

Blood (2025) 146 (Supplement 1): 5522.

https://doi.org/10.1182/blood-2025-5522

Published: 2025

Journal Articles

Title first‑in‑human Phase 1 dose‑finding study (VIPER 101) of dual‑population autologous CD5‑deleted anti-CD5 CAR‑T (Senza5 CART5) cells in Relapsed/Refractory T‑cell lymphomas

Stefan Barta, Stephen Schuster, Jakub Svoboda, Jordan Carter, Elise Chong, Daniel Landsburg, Sunita Dwivedy Nasta, Ruchi Patel, Joseph Fraietta, Colin Thomas, Omar Elghawy, Ran Reshef, Aditya Nimmagadda, Lavanya Peddada, Adam Snook, Nicholas Siciliano, Rosemary Mazanet, Marco Ruella

Blood (2025) 146 (Supplement 1): 4174.

https://doi.org/10.1182/blood-2025-4174

Published: 2025

Journal Articles

BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter, showing promising efficacy in T cell lymphoma patients

Stefan Barta, Christiane Querfeld, Sean Lim, Ana Carneiro, Stephen Morris, Jeffrey Yachnin, Marica Vaapil, Susanne Gertsson, Petra Holmkvist, Ingrid Karlsson, Linda Mårtensson, Dmytro Piliuhin, Ingrid Teige, Johan Wallin, Björn Frendeus, Andres McAllister

Blood (2025) 146 (Supplement 1): 3633.

https://doi.org/10.1182/blood-2025-3633

Published: 2025

Journal Articles

A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study

Blood (2025) 146 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2025-3617

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

IL18-armored CAR T cells in patients with CLL/SLL and Richter's transformation after prior BTK inhibitor and venetoclax failure

Evaluation of outcomes by line of therapy in marginal zone lymphoma: Real-world evidence from 10 US academic centers

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Outcomes of patients with dual primary T-cell and B-cell lymphoid malignancies

Early administration of CD20 x CD3 bispecific antibodies 4-6 weeks after CAR-T infusion for patients with residual or progressive large B cell lymphomas

Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort

Frontline experience with second generation covalent Bruton tyrosine kinase inhibitors for mantle cell lymphoma: A single center experience

Patient characteristics, treatment patterns, and outcomes in primary CNS lymphoma of T-cell origin: A multi-institution retrospective analysis

Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium

Trends in muscle and fat metrics and their association with outcomes following CAR T-cell therapy in older adults with non Hodgkin lymphoma.

A multicenter real-world analysis (RWA) of primary cutaneous anaplastic large cell lymphoma (PCALCL) treated in the era of targeted therapies

Naive CD4+ at apheresis and disease control at infusion are associated with improved efficacy in second-line CAR T-cells

Duration of lymphopenia after CAR-T cell therapy is associated with increased risk of non-melanoma skin cancers and decreased survival

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden

CD19-directed CAR T-cell therapy for B-cell lymphoid malignancies is safe and effective in people living with HIV (PWH) – a matched cohort analysis by the center for international blood and marrow transplant research (CIBMTR) and the AIDS malignancy consortium (AMC)

Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study

Risk factors for failure to complete step-up-dosing of bispecific antibody therapy for B-cell lymphomas

Title first‑in‑human Phase 1 dose‑finding study (VIPER 101) of dual‑population autologous CD5‑deleted anti-CD5 CAR‑T (Senza5 CART5) cells in Relapsed/Refractory T‑cell lymphomas

BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter, showing promising efficacy in T cell lymphoma patients

A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only